Spinal pump may ease cancer pain when pills fail

NCT ID NCT05674240

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a device that delivers pain medicine directly to the spinal cord for cancer patients with severe pain not controlled by oral opioids. Researchers compared the pump to standard medical management in 30 adults. The goal was to see if the pump reduces pain intensity and improves quality of life.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Intrathecal Targeted Drug Delivery (Medtronic SynchroMed™ II pump)

What this could lead to

If it works, this could offer better pain control and fewer side effects for cancer patients who don't get relief from oral opioids.

What could go wrong

This is a small, completed registry study (30 people), not a large trial. The pump requires surgery and carries risks like infection or device problems.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEUROPATHIC PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer Cancer Pain Chronic Pain chronic pain syndrome neuralgia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Advocate Aurora Health

    Oshkosh, Wisconsin, 54904, United States